|
|
||||||||



,2
*
Laboratory of Experimental Immunology, Université Libre de Bruxelles, Brussels, Belgium; Departments of
Nephrology and
Pathology, Hôpital Erasme, Brussels, Belgium;
§
Unit of Cellular Pharmacology, Associated Unit of Pasteur Institute/Institue National de la Santé et de la Recherche Médicale, Unité 485 and Institue National de la Santé et de la Recherche Médicale, Unité U 408; and
¶
Faculté de Médecine Xavier-Bichat, Paris, France
CD4 T cells play a crucial role in the acute rejection of MHC class II-disparate skin allografts, mainly by Fas/Fas ligand-mediated cytotoxicity. Because recent observations indicate that eosinophils may be found within allografts rejected by CD4 T cells, we evaluated the role played by IL-5, the main eosinophil growth factor, and by eosinophils in the rejection of MHC class II-disparate skin grafts. C57BL/6 mice rapidly rejected MHC class II-disparate bm12 skin grafts. Rejected skins contained a dense, aggressive eosinophil infiltrate. Lymphocytes isolated from lymph nodes draining rejected bm12 skin were primed for IL-5 secretion, and IL-5 mRNA was present within rejected grafts. The IL-5/eosinophil pathway played an effector role in allograft destruction, because the rejection of bm12 skin was significantly delayed in IL-5-deficient mice as compared with wild-type animals. The role of the IL-5/eosinophil pathway was further investigated in MHC class II-disparate donor-recipient strains unable to establish Fas/Fas ligand interactions. Fas ligand-deficient gld/gld mice rejected bm12 skins, and bm12 mice rejected Fas-deficient lpr/lpr C57BL/6 skins. Neutralization of IL-5 prevented acute rejection in both combinations. We conclude that MHC class II-disparate skin allografts trigger an IL-5-dependent infiltration of eosinophils that is sufficient to result in acute graft destruction.
This article has been cited by other articles:
![]() |
B. E. Burrell, G. Lu, X. C. Li, and D. K. Bishop OX40 Costimulation Prevents Allograft Acceptance Induced by CD40-CD40L Blockade J. Immunol., January 1, 2009; 182(1): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Flynn, M. Ohbayashi, Y. Ikeda, S. J. Ono, and D. F. Larkin Effect of Allergic Conjunctival Inflammation on the Allogeneic Response to Donor Cornea Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4044 - 4049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buonocore, F. Paulart, A. Le Moine, M. Braun, I. Salmon, S. Van Meirvenne, K. Thielemans, M. Goldman, and V. Flamand Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo Blood, February 15, 2003; 101(4): 1469 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Coudert, C. Coureau, and J.-C. Guery Preventing NK Cell Activation by Donor Dendritic Cells Enhances Allospecific CD4 T Cell Priming and Promotes Th Type 2 Responses to Transplantation Antigens J. Immunol., September 15, 2002; 169(6): 2979 - 2987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Surquin, A. Le Moine, V. Flamand, N. Nagy, K. Rombaut, F.-X. Demoor, P. Stordeur, I. Salmon, J.-C. Guery, M. Goldman, et al. Skin Graft Rejection Elicited by {beta}2-Microglobulin as a Minor Transplantation Antigen Involves Multiple Effector Pathways: Role of Fas-Fas Ligand Interactions and Th2-Dependent Graft Eosinophil Infiltrates J. Immunol., July 1, 2002; 169(1): 500 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Braun, I. Grandjean, P. Feunou, L. Duban, R. Kiss, M. Goldman, and O. Lantz Acute Rejection in the Absence of Cognate Recognition of Allograft by T Cells J. Immunol., April 15, 2001; 166(8): 4879 - 4883. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhou, G. L. Szot, Z. Guo, O. Kim, G. He, J. Wang, M. J. Grusby, K. A. Newell, J. R. Thistlethwaite, J. A. Bluestone, et al. Role of STAT4 and STAT6 Signaling in Allograft Rejection and CTLA4-Ig-Mediated Tolerance J. Immunol., November 15, 2000; 165(10): 5580 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Foucras, J. D. Coudert, C. Coureau, and J.-C. Guery Dendritic Cells Prime In Vivo Alloreactive CD4 T Lymphocytes Toward Type 2 Cytokine- and TGF-{beta}-Producing Cells in the Absence of CD8 T Cell Activation J. Immunol., November 1, 2000; 165(9): 4994 - 5003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |